NO20033683D0 - 2,4-disubstituerte pyrimidin-5-karboksamidderivater som KCNQ kaliumkanal modulatorer - Google Patents
2,4-disubstituerte pyrimidin-5-karboksamidderivater som KCNQ kaliumkanal modulatorerInfo
- Publication number
- NO20033683D0 NO20033683D0 NO20033683A NO20033683A NO20033683D0 NO 20033683 D0 NO20033683 D0 NO 20033683D0 NO 20033683 A NO20033683 A NO 20033683A NO 20033683 A NO20033683 A NO 20033683A NO 20033683 D0 NO20033683 D0 NO 20033683D0
- Authority
- NO
- Norway
- Prior art keywords
- potassium channel
- channel modulators
- carboxamide derivatives
- kcnq potassium
- disubstituted pyrimidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26980001P | 2001-02-20 | 2001-02-20 | |
PCT/US2002/004305 WO2002066036A1 (en) | 2001-02-20 | 2002-02-14 | 2,4-disubstituted pyrimidine-5-carboxamide derivatives as kcnq potassium channel modulators |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20033683D0 true NO20033683D0 (no) | 2003-08-19 |
NO20033683L NO20033683L (no) | 2003-10-17 |
Family
ID=23028698
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20033683A NO20033683L (no) | 2001-02-20 | 2003-08-19 | 2,4-disubstituerte pyrimidin-5-karboksamidderivater som KCNQ kaliumkanal modulatorer |
Country Status (10)
Country | Link |
---|---|
US (1) | US20020183335A1 (no) |
EP (1) | EP1361879A1 (no) |
JP (1) | JP2005508833A (no) |
CA (1) | CA2438231A1 (no) |
CZ (1) | CZ20032233A3 (no) |
HU (1) | HUP0303841A2 (no) |
MX (1) | MXPA03007395A (no) |
NO (1) | NO20033683L (no) |
PL (1) | PL372944A1 (no) |
WO (1) | WO2002066036A1 (no) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2463989C (en) * | 2001-10-17 | 2012-01-31 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pyrimidine derivatives, pharmaceutical compositions containing these compounds, the use thereof and process for the preparation thereof |
EP1453516A2 (de) | 2001-10-17 | 2004-09-08 | Boehringer Ingelheim Pharma GmbH & Co.KG | 5-substituierte 4-amino-2-phenylamino-pyrimdinderivate und ihre verwendung als beta-amyloid modulatoren |
US7205307B2 (en) | 2002-02-14 | 2007-04-17 | Icagen, Inc. | Pyrimidines as novel openers of potassium ion channels |
US7176310B1 (en) * | 2002-04-09 | 2007-02-13 | Ucb Sa | Pyrimidinecarboxamide derivatives and their use as anti-inflammatory agents |
ES2273077T3 (es) * | 2002-08-21 | 2007-05-01 | Glaxo Group Limited | Derivados de 2-fenilamino-4-trifluorometil-5 (bencil- o piridin-4-il-metil) carbamoilpirimidina como moduladores selectivos del receptor cannabinoide cb2. |
UY27939A1 (es) | 2002-08-21 | 2004-03-31 | Glaxo Group Ltd | Compuestos |
US7459460B2 (en) * | 2003-05-28 | 2008-12-02 | Bristol-Myers Squibb Company | Trisubstituted heteroaromatic compounds as calcium sensing receptor modulators |
PE20051029A1 (es) * | 2003-07-02 | 2005-12-07 | Vertex Pharma | Pirimidinas moduladoras de canales ionicos regulados por voltaje |
MXPA06006120A (es) * | 2003-12-01 | 2007-04-16 | Kudos Pharm Ltd | Inhibidores de reparacion de dano de acido desoxirribonucleico para tratamiento de cancer. |
GB0402356D0 (en) * | 2004-02-03 | 2004-03-10 | Glaxo Group Ltd | Novel compounds |
GB0404105D0 (en) * | 2004-02-24 | 2004-03-31 | Glaxo Group Ltd | Novel compounds |
TWI357901B (en) | 2004-03-12 | 2012-02-11 | Lundbeck & Co As H | Substituted morpholine and thiomorpholine derivati |
AU2005232745A1 (en) | 2004-04-13 | 2005-10-27 | Astellas Pharma Inc. | Polycyclic pyrimidines as potassium ion channel modulators |
WO2006047504A1 (en) * | 2004-10-22 | 2006-05-04 | Janssen Pharmaceutica, N.V. | Aromatic amides as inhibitors of c-fms kinase |
US7767680B2 (en) | 2004-11-03 | 2010-08-03 | Vertex Pharmaceuticals Incorporated | Ion channel modulators and methods of use |
UA92340C2 (en) * | 2005-03-03 | 2010-10-25 | Х. Луннбек А/С | Substituted pyridine derivatives |
US7812020B2 (en) * | 2005-03-03 | 2010-10-12 | H. Lundbeck A/S | Substituted pyridine derivatives |
EP1863796A1 (en) * | 2005-03-22 | 2007-12-12 | NeuroSearch A/S | Pyrazolyl-pyrimidines as potassium channel modulating agents and their medical use |
DE102005038947A1 (de) | 2005-05-18 | 2006-11-30 | Grünenthal GmbH | Substituierte Benzo[d]isoxazol-3-yl-amin-Verbindungen und deren Verwendung in Arzneimitteln |
EP1904491A2 (en) * | 2005-05-31 | 2008-04-02 | Vertex Pharmaceuticals Incorporated | Heterocycles useful as modulators of ion channels |
US7683058B2 (en) | 2005-09-09 | 2010-03-23 | H. Lundbeck A/S | Substituted pyrimidine derivatives |
BRPI0615631A2 (pt) * | 2005-09-09 | 2011-05-24 | Lundbeck & Co As H | composto, composição farmacêutica, e, uso de uma composição farmacêutica |
CA2679198C (en) | 2007-02-26 | 2011-07-12 | Pfizer Products Inc. | Nicotinamide derivatives as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases |
MX2010010209A (es) | 2008-03-18 | 2010-10-05 | Merck Sharp & Dohme | 4-hidroxipirimidina-5-carboxamidas sustituidas. |
TWI504395B (zh) | 2009-03-10 | 2015-10-21 | Substituted 3-amino-2-mercaptoquinoline as a KCNQ2 / 3 modifier | |
TWI475020B (zh) * | 2009-03-12 | 2015-03-01 | The substituted nicotine amide as a KCNQ2 / 3 modifier | |
TW201038565A (en) | 2009-03-12 | 2010-11-01 | Gruenenthal Gmbh | Substituted 2-mercapto-3-aminopyridines as KCNQ2/3 modulators |
TWI461197B (zh) | 2009-03-12 | 2014-11-21 | 2-mercaptoquinoline-3-carboxamide as a KCNQ2 / 3 modifier | |
CA2804165C (en) * | 2010-07-08 | 2015-02-24 | Pfizer Inc. | Piperidinyl pyrimidine amides as kv7 potassium channel openers |
BR112013004690A2 (pt) | 2010-08-27 | 2016-05-10 | Gruenenthal Gmbh | 2-oxo-e 2-tioxo-di-hidroquinolina-3-carboxamidas substituídas como moduladores kcnq2/3 |
US8653101B2 (en) | 2010-08-27 | 2014-02-18 | Gruenenthal Gmbh | Substituted 2-oxy-quinoline-3-carboxamides as KCNQ2/3 modulators |
US8470852B2 (en) | 2010-08-27 | 2013-06-25 | Gruenenthal Gmbh | Substituted 2-amino-quinoline-3-carboxamides as KCNQ2/3 modulators |
CA2807886A1 (en) | 2010-09-01 | 2012-03-08 | Gruenenthal Gmbh | Substituted 1-oxo-dihydroisoquinoline-3-carboxamides as kcnq2/3 modulators |
US9168259B2 (en) | 2010-10-20 | 2015-10-27 | Grünenthal GmbH | Substituted 6-amino-nicotinamides as KCNQ2/3 modulators |
PE20140199A1 (es) | 2010-10-20 | 2014-02-16 | Gruenenthal Chemie | 6-amino-nicotinamidas sustituidas como moduladores de kcnq2/3 |
MX2014012491A (es) | 2012-04-18 | 2014-11-14 | Grünenthal GmbH | 4-aminobenzamidas sustituidas como moduladores de kcnq2/3. |
CA2870573A1 (en) | 2012-04-18 | 2013-10-24 | Grunenthal Gmbh | Substituted 6-amino-nicotinamides bearing an oh-containing group as kcnq2/3 modulators |
BR112015012418A2 (pt) | 2012-11-28 | 2017-07-11 | Gruenenthal Gmbh | carboxamidas específicas como moduladores de kcnq2/3 |
US9248122B2 (en) | 2012-11-28 | 2016-02-02 | Grünenthal GmbH | Heteroquinoline-3-carboxamides as KCNQ2/3 modulators |
MX2015006688A (es) * | 2012-11-28 | 2015-08-10 | Grünenthal GmbH | Amino-arilcarboxamidas sustituidas como moduladores de kcnq2/3. |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5852028A (en) * | 1995-12-18 | 1998-12-22 | Signal Pharmaceuticals, Inc. | Pyrimidine carboxylates and related compounds and methods for treating inflammatory conditions |
US5811428A (en) * | 1995-12-18 | 1998-09-22 | Signal Pharmaceuticals, Inc. | Pyrimidine carboxamides and related compounds and methods for treating inflammatory conditions |
US5935966A (en) * | 1995-09-01 | 1999-08-10 | Signal Pharmaceuticals, Inc. | Pyrimidine carboxylates and related compounds and methods for treating inflammatory conditions |
TW550258B (en) * | 1999-05-31 | 2003-09-01 | Hoffmann La Roche | 4-phenyl-pyrimidine derivatives |
CA2378243C (en) * | 1999-08-04 | 2012-05-15 | Icagen, Inc. | Methods for treating or preventing pain and anxiety |
IL157313A0 (en) * | 2001-02-20 | 2004-02-19 | Bristol Myers Squibb Co | Modulators of kcnq potassium channels and uses thereof |
-
2002
- 2002-02-14 MX MXPA03007395A patent/MXPA03007395A/es unknown
- 2002-02-14 EP EP02709517A patent/EP1361879A1/en not_active Withdrawn
- 2002-02-14 PL PL02372944A patent/PL372944A1/xx not_active Application Discontinuation
- 2002-02-14 US US10/075,521 patent/US20020183335A1/en not_active Abandoned
- 2002-02-14 WO PCT/US2002/004305 patent/WO2002066036A1/en not_active Application Discontinuation
- 2002-02-14 CA CA002438231A patent/CA2438231A1/en not_active Abandoned
- 2002-02-14 HU HU0303841A patent/HUP0303841A2/hu unknown
- 2002-02-14 JP JP2002565594A patent/JP2005508833A/ja active Pending
- 2002-02-14 CZ CZ20032233A patent/CZ20032233A3/cs unknown
-
2003
- 2003-08-19 NO NO20033683A patent/NO20033683L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
PL372944A1 (en) | 2005-08-08 |
HUP0303841A2 (hu) | 2004-03-01 |
JP2005508833A (ja) | 2005-04-07 |
NO20033683L (no) | 2003-10-17 |
CA2438231A1 (en) | 2002-08-29 |
MXPA03007395A (es) | 2003-12-04 |
EP1361879A1 (en) | 2003-11-19 |
CZ20032233A3 (cs) | 2004-12-15 |
US20020183335A1 (en) | 2002-12-05 |
WO2002066036A1 (en) | 2002-08-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20033683D0 (no) | 2,4-disubstituerte pyrimidin-5-karboksamidderivater som KCNQ kaliumkanal modulatorer | |
NO20012739D0 (no) | 3-substituerte-4-arylquinolin-2-on-derivater som kaliumkanal modulatorer | |
DK1446394T3 (da) | Hidtil ukendte 1,2,4-thiadiazolderivater som melanocortinreceptormodulatorer | |
DK1414803T3 (da) | Pyrazolylcarboxanilider som fungicider | |
NO20035245L (no) | Grunnleggende Wi-Fi-arkitektur for 802.11-nettverk | |
NO20052995D0 (no) | 1,5-diaryl-pyrrol-3-karboksamid-derivater, og deres anvendelse som kannabinoid reseptormodulatorer. | |
NO20034930L (no) | Substituerte cykloheksan-1,4-diaminderivater | |
NO20022649D0 (no) | Heterocykliske dihydropyrimidiner som kaliumkanal inhibitorer | |
NO20040632L (no) | 2-amino-4,5-trisubstituerte tiazolylderivater. | |
DK1593670T3 (da) | Hydroxysubstituerede 2-azetidinoner, der er anvendelige som hypokolesterolæmiske midler | |
NO20033353D0 (no) | Karotenoid biosyntese | |
DK1429607T3 (da) | Delta-1-pyrroliner som pesticider | |
DK1339685T3 (da) | Biphenylcarboxamider, der er egnede som lipidsænkende midler | |
DE60210598D1 (de) | 3,7-DIAZABICYCLOc3.3.1Ü-FORMULIERUNGEN ALS ANTIARRHYTHMIKA | |
DK1330458T3 (da) | N-(1,2,4-triazoloazinyl)thiophensulfonamidforbindelser som herbicider | |
NO20033234L (no) | Karotenoider som antihypertensjonsmidler | |
NO20005570D0 (no) | Cyklopentanondihydropyridinforbindelser anvendbare som kaliumkanalÕpnere | |
NO20044413L (no) | 1,2-Dihydropyrazol-3-oner som cytokinmediatorer | |
DE60213084D1 (de) | 3,7-DIAZABICYCLOc3.3.1Ü-FORMULIERUNGEN ALS ANTIARRHYTHMIKA | |
ITTO20020747A1 (it) | Composizione. | |
DK1349850T3 (da) | Natriumkanalmodulatorer, der er afledt af 2-piperidylimidazoler | |
ITMI20022183A1 (it) | Cerniera. | |
DK1487802T3 (da) | 2,3-diaryl-pyrazolidin-derivater som neurotensin-nedbrydende enzyminhibitorer | |
ITTO20020745A1 (it) | Composizione. | |
IS7131A (is) | Nýjar 2,4-díamínóþíasól afleiður |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |